Ludwig Enterprises Inc. Stock Analysis LUDG
Ludwig Enterprises Inc, operates as a biotech and healthcare holding company. The company is headquartered in Pompano Beach, Florida and currently employs 5 full-time employees. The company went IPO on 2007-12-11. Its proprietary mRNA genomic technology has the potential of screening for genetic biomarkers for inflammatory-driven diseases, including, but not limited to, heart disease, diabetes, preeclampsia, cancer and long COVID. The firm employs a non-invasive cheek swab test to collect mRNA samples. Its initial product candidate is the Revealia Breast test, a non-invasive cheek swab assay designed to detect molecular signatures in mRNA expression associated with the presence of breast cancer. Its technology platform integrates three key components: non-invasive sample collection, genomic analysis, and machine learning-based interpretation.
Read More Ludwig Enterprises Inc (LUDG) Chart
Key Statistics of Ludwig Enterprises Inc (LUDG)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.03Volume
1350.00P/E Ratio (TTM)
-52 Week Range
Market Cap
5.33MAvg. Volume
9526.77Dividend Yield
-Financial Metrics & Statements of Ludwig Enterprises Inc (LUDG)
FAQ's for Ludwig Enterprises Inc (LUDG)
- According to Musaffa’s Shariah screening methodology, Ludwig Enterprises Inc (LUDG) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.